Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Microbiol ; 10: 1375, 2019.
Article in English | MEDLINE | ID: mdl-31275288

ABSTRACT

In 2014, a novel species of Acinetobacter, strain A47, determined to be hospital-acquired was recovered from a single patient soft tissue sample following a traumatic accident. The complexity of the Acinetobacter genus has been established, and every year novel species are identified. However, specific features and virulence factors that allow members of this genus to be successful pathogens are not well understood. Utilizing both genomic and phenotypic approaches, we identified distinct features and potential virulence factors of the A47 strain to understand its pathobiology. In silico analyses confirmed the uniqueness of this strain and other comparative and sequence analyses were used to study the evolution of relevant features identified in this isolate. The A47 genome was further analyzed for genes associated with virulence and genes involved in type IV pili (T4P) biogenesis, hemolysis, type VI secretion system (T6SS), and novel antibiotic resistance determinants were identified. A47 exhibited natural transformation with both genomic and plasmid DNA. It was able to form biofilms on different surfaces, to cause hemolysis of sheep and rabbit erythrocytes, and to kill competitor bacteria. Additionally, surface structures with non-uniform length were visualized with scanning electron microscopy and proposed as pili-like structures. Furthermore, the A47 genome revealed the presence of two putative BLUF type photoreceptors, and phenotypic assays confirmed the modulation by light of different virulence traits. Taken together, these results provide insight into the pathobiology of A47, which exhibits multiple virulence factors, natural transformation, and the ability to sense and respond to light, which may contribute to the success of an A47 as a hospital dwelling pathogen.

2.
Int J Antimicrob Agents ; 53(4): 483-490, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30611868

ABSTRACT

The human pathogen Acinetobacter baumannii possesses high genetic plasticity and frequently acquires antimicrobial resistance genes. Here we investigated the role of natural transformation in these processes. Genomic DNA from different sources, including from carbapenem-resistant Klebsiella pneumoniae strains, was mixed with A. baumannii A118 cells. Selected transformants were analysed by whole-genome sequencing. In addition, bioinformatics analyses and in silico gene flow prediction were also performed to support the experimental results. Transformant strains included some that became resistant to carbapenems or changed their antimicrobial susceptibility profile. Foreign DNA acquisition was confirmed by whole-genome analysis. The acquired DNA most frequently identified corresponded to mobile genetic elements, antimicrobial resistance genes and operons involved in metabolism. Bioinformatics analyses and in silico gene flow prediction showed continued exchange of genetic material between A. baumannii and K. pneumoniae when they share the same habitat. Natural transformation plays an important role in the plasticity of A. baumannii and concomitantly in the emergence of multidrug-resistant strains.


Subject(s)
Acinetobacter baumannii/drug effects , Acinetobacter baumannii/genetics , Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , DNA, Bacterial/metabolism , Drug Resistance, Multiple, Bacterial/genetics , Klebsiella pneumoniae/genetics , Transformation, Bacterial/genetics , Carbapenem-Resistant Enterobacteriaceae/genetics , DNA, Bacterial/genetics , Genome, Bacterial/genetics , Humans , Interspersed Repetitive Sequences/genetics , Klebsiella pneumoniae/drug effects , Microbial Sensitivity Tests , Whole Genome Sequencing
3.
Sci Rep ; 8(1): 14741, 2018 10 03.
Article in English | MEDLINE | ID: mdl-30282985

ABSTRACT

In the past few decades Acinetobacter baumannii has emerged as a notorious nosocomial pathogen because of its ability to acquire genetic material and persist in extreme environments. Recently, human serum albumin (HSA) was shown to significantly increase natural transformation frequency in A. baumannii. This observation led us to perform transcriptomic analysis of strain A118 under HSA induction to identify genes that are altered by HSA. Our results revealed the statistically significant differential expression of 296 protein-coding genes, including those associated with motility, biofilm formation, metabolism, efflux pumps, capsule synthesis, and transcriptional regulation. Phenotypic analysis of these traits showed an increase in surface-associated motility, a decrease in biofilm formation, reduced activity of a citric acid cycle associated enzyme, and increased survival associated with zinc availability. Furthermore, the expression of genes known to play a role in pathogenicity and antibiotic resistance were altered. These genes included those associated with RND-type efflux pumps, the type VI secretion system, iron acquisition/metabolism, and ß-lactam resistance. Together, these results illustrate how human products, in particular HSA, may play a significant role in both survival and persistence of A. baumannii.


Subject(s)
Acinetobacter baumannii/drug effects , Gene Expression Regulation, Bacterial/drug effects , Genome, Bacterial , Serum Albumin, Human/pharmacology , beta-Lactam Resistance/drug effects , Acinetobacter baumannii/genetics , Acinetobacter baumannii/metabolism , Acinetobacter baumannii/pathogenicity , Bacterial Capsules/drug effects , Bacterial Capsules/genetics , Bacterial Capsules/metabolism , Biofilms , Citric Acid Cycle/drug effects , Citric Acid Cycle/genetics , Gene Expression Profiling , Genes, MDR/drug effects , Humans , Ion Transport/drug effects , Iron/metabolism , Microbial Viability/drug effects , Transformation, Bacterial/drug effects , Type VI Secretion Systems/genetics , Type VI Secretion Systems/metabolism , Zinc/metabolism , beta-Lactam Resistance/genetics , beta-Lactams/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...